Insights on Transitioning From Medicaid to the New Medicare Prescription Drug Benefit

The Kaiser Commission on Medicaid and the Uninsured convened a focus group of state Medicaid officials in November 2005 to discuss the impact of the new Medicare drug program on states and Medicaid enrollees. State insights on the transition of dual eligibles and some beneficiary experiences are discussed in new material and an audio briefing.

podcasticon.gif Podcast: December 19, 2005 Conference Call Briefing (Downloadable Audio File)

icon_presentations.gifPresentations from the December 19, 2005 Conference Call Briefing (.pdf)

An Implementation Perspective On Part D, The Medicare Prescription Drug Program

Profiles of Medicare Beneficiaries With Medicaid Drug Coverage Prior to the Medicare Drug Benefit (.pdf)

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.